Homo sapiens Protein: FOXL2
Summary
InnateDB Protein IDBP-58708.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol FOXL2
Protein Name forkhead box L2
Synonyms BPES; BPES1; PFRK; PINTO; POF3;
Species Homo sapiens
Ensembl Protein ENSP00000333188
InnateDB Gene IDBG-58706 (FOXL2)
Protein Structure
UniProt Annotation
Function Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans- differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Participates in SMAD3-dependent transcription of FST via the intronic SMAD-binding element (By similarity). Is a transcriptional repressor of STAR. Activates SIRT1 transcription under cellular stress conditions. Activates transcription of OSR2. {ECO:0000250, ECO:0000269PubMed:16153597, ECO:0000269PubMed:19010791, ECO:0000269PubMed:19429596, ECO:0000269PubMed:19744555}.
Subcellular Localization Nucleus {ECO:0000255PROSITE- ProRule:PRU00089, ECO:0000269PubMed:19744555}.
Disease Associations Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]: A disorder characterized by eyelid dysplasia, small palpebral fissures, drooping eyelids and a skin fold curving in the mediolateral direction, inferior to the inner canthus. In type I BPSE (BPES1) eyelid abnormalities are associated with female infertility. Affected females show an ovarian deficit due to primary amenorrhea or to premature ovarian failure (POF). In type II BPSE (BPES2) affected individuals show only the eyelid defects. {ECO:0000269PubMed:11175783, ECO:0000269PubMed:11468277, ECO:0000269PubMed:12400065, ECO:0000269PubMed:12529855, ECO:0000269PubMed:12630957, ECO:0000269PubMed:12938087, ECO:0000269PubMed:15257268, ECO:0000269PubMed:16454982, ECO:0000269PubMed:17089161, ECO:0000269PubMed:18484667, ECO:0000269PubMed:18642388, ECO:0000269Ref.2}. Note=The disease is caused by mutations affecting the gene represented in this entry. There is a mutational hotspot in the region coding for the poly-Ala domain, since 30% of all mutations in the ORF lead to poly-Ala expansions, resulting mainly in BPES type II.Premature ovarian failure 3 (POF3) [MIM:608996]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269PubMed:12149404, ECO:0000269PubMed:19429596}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity In addition to its expression in the developing eyelid, it is transcribed very early in somatic cells of the developing gonad (before sex determination) and its expression persists in the follicular cells of the adult ovary.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 7 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated
Total 7 [view]
Protein-Protein 7 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0003700 sequence-specific DNA binding transcription factor activity
GO:0005515 protein binding
GO:0030331 estrogen receptor binding
GO:0031624 ubiquitin conjugating enzyme binding
GO:0043028 cysteine-type endopeptidase regulator activity involved in apoptotic process
GO:0043565 sequence-specific DNA binding
Biological Process
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0001541 ovarian follicle development
GO:0002074 extraocular skeletal muscle development
GO:0006309 apoptotic DNA fragmentation
GO:0006355 regulation of transcription, DNA-templated
GO:0006366 transcription from RNA polymerase II promoter
GO:0019101 female somatic sex determination
GO:0030154 cell differentiation
GO:0042703 menstruation
GO:0043065 positive regulation of apoptotic process
GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0045892 negative regulation of transcription, DNA-templated
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0048048 embryonic eye morphogenesis
GO:0060014 granulosa cell differentiation
Cellular Component
GO:0005634 nucleus
Protein Structure and Domains
PDB ID
InterPro IPR001766 Transcription factor, fork head
PFAM PF00250
PRINTS PR00053
PIRSF
SMART SM00339
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P58012
PhosphoSite PhosphoSite-P58012
TrEMBL Q53ZD3
UniProt Splice Variant
Entrez Gene 668
UniGene Hs.614426
RefSeq NP_075555
HUGO HGNC:1092
OMIM 605597
CCDS CCDS3105
HPRD 05723
IMGT
EMBL AF301906 AY331134 BC062549 DQ016593 DQ016608 DQ016609 DQ089670 DQ089672
GenPept AAH62549 AAK01352 AAQ01519 AAY21821 AAY21822 AAY21823 AAY89234 AAY89236